852 related articles for article (PubMed ID: 17493708)
1. A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation.
Fresco P; Oliveira JM; Kunc F; Soares AS; Rocha-Pereira C; Gonçalves J; Diniz C
Neurochem Int; 2007 Jul; 51(1):47-56. PubMed ID: 17493708
[TBL] [Abstract][Full Text] [Related]
2. Interaction between adenosine A 2B-receptors and alpha2-adrenoceptors on the modulation of noradrenaline release in the rat vas deferens: possible involvement of a group 2 adenylyl cyclase isoform.
Talaia C; Queiroz G; Quintas C; Gonçalves J
Neurochem Int; 2005 Nov; 47(6):418-29. PubMed ID: 16040158
[TBL] [Abstract][Full Text] [Related]
3. Involvement of G-protein βγ subunits on the influence of inhibitory α2-autoreceptors on the angiotensin AT1-receptor modulation of noradrenaline release in the rat vas deferens.
Talaia C; Queiroz G; Pinheiro H; Moura D; Gonçalves J
Neurochem Int; 2006 Dec; 49(7):698-707. PubMed ID: 16962210
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery.
Fresco P; Diniz C; Gonçalves J
Cardiovasc Res; 2004 Sep; 63(4):739-46. PubMed ID: 15306230
[TBL] [Abstract][Full Text] [Related]
5. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery.
Diniz C; Fresco P; Leal S; Gonçalves J
Eur J Pharmacol; 2004 Nov; 504(1-2):17-25. PubMed ID: 15507216
[TBL] [Abstract][Full Text] [Related]
6. The P2Y(1) and P2Y(12) receptors mediate autoinhibition of transmitter release in sympathetic innervated tissues.
Quintas C; Fraga S; Gonçalves J; Queiroz G
Neurochem Int; 2009 Dec; 55(7):505-13. PubMed ID: 19447154
[TBL] [Abstract][Full Text] [Related]
7. Coupling to protein kinases A and C of adenosine A2B receptors involved in the facilitation of noradrenaline release in the prostatic portion of rat vas deferens.
Queiroz G; Quintas C; Talaia C; Gonçalves J
Neuropharmacology; 2004 Aug; 47(2):216-24. PubMed ID: 15223300
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor-mediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens.
Queiroz G; Talaia C; Gonçalves J
J Neurochem; 2003 May; 85(3):740-8. PubMed ID: 12694400
[TBL] [Abstract][Full Text] [Related]
9. Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery.
Fresco P; Diniz C; Queiroz G; Gonçalves J
Br J Pharmacol; 2002 May; 136(2):230-6. PubMed ID: 12010771
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A1 receptor-mediated inhibition of myocardial norepinephrine release involves neither phospholipase C nor protein kinase C but does involve adenylyl cyclase.
Schütte F; Burgdorf C; Richardt G; Kurz T
Can J Physiol Pharmacol; 2006 May; 84(5):573-7. PubMed ID: 16902603
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
12. Chronic morphine acts via a protein kinase Cgamma-G(beta)-adenylyl cyclase complex to augment phosphorylation of G(beta) and G(betagamma) stimulatory adenylyl cyclase signaling.
Chakrabarti S; Regec A; Gintzler AR
Brain Res Mol Brain Res; 2005 Jul; 138(1):94-103. PubMed ID: 15908039
[TBL] [Abstract][Full Text] [Related]
13. Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase activation via G beta gamma subunit signaling.
Kushwaha N; Albert PR
Eur J Neurosci; 2005 Feb; 21(3):721-32. PubMed ID: 15733090
[TBL] [Abstract][Full Text] [Related]
14. Loss of association between activated Galpha q and Gbetagamma disrupts receptor-dependent and receptor-independent signaling.
Evanko DS; Thiyagarajan MM; Takida S; Wedegaertner PB
Cell Signal; 2005 Oct; 17(10):1218-28. PubMed ID: 16038796
[TBL] [Abstract][Full Text] [Related]
15. Selective modulation of noradrenaline release by alpha 2-adrenoceptor blockade in the rat-tail artery in vitro.
Brock JA; Tan JH
Br J Pharmacol; 2004 May; 142(2):267-74. PubMed ID: 15155535
[TBL] [Abstract][Full Text] [Related]
16. Adenosine activating A(2A)-receptors coupled to adenylate cyclase/cyclic AMP pathway downregulates nicotinic autoreceptor function at the rat myenteric nerve terminals.
Duarte-Araújo M; Timóteo MA; Correia-de-Sá P
Neurochem Int; 2004 Oct; 45(5):641-51. PubMed ID: 15234106
[TBL] [Abstract][Full Text] [Related]
17. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
18. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
19. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the signal transduction pathways mediating noradrenaline-stimulated MAPK activation and c-fos expression in oligodendrocyte progenitors.
Khorchid A; Larocca JN; Almazan G
J Neurosci Res; 1999 Dec; 58(6):765-78. PubMed ID: 10583908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
